Association of nonalcoholic fatty liver disease with insulin resistance

American Journal of Medicine

Volumn 107, Issue 5, 1999, Pages 450-455

  Marchesini, Giulio ^a,c   Brizi, Mara ^a   Morselli Labate, Antonio M ^a   Bianchi, Giampaolo ^a   Bugianesi, Elisabetta ^a   McCullough, Arthur J ^b   Forlani, Gabriele ^a   Melchionda, Nazario ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b METROHEALTH MEDICAL CENTER   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIVER DISEASE; LIVER FUNCTION; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO;

EID: 0033231294     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00271-5     Document Type: Article

References (35)

1. Ludwig J., Viaggiano T.R., McGill D.B., Oh B.J. Nonalcoholic steatohepatitis Mayo Clinic experience with an hitherto unnamed disease . Mayo Clin Proc. 55:1980;434-438.
2. Leevy C.M. Fatty liver. A study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine. 41:1962;249-276.
3. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity an autopsy study with analysis of risk factors . Hepatology. 12:1990;1106-1110.
4. Eriksson S., Eriksson K.F., Bondesson L. Nonalcoholic steatohepatitis in obesity a reversible condition . Acta Med Scand. 220:1986;83-88.
5. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis a follow-up study of forty-two patients for up to 21 years . Hepatology. 11:1990;74-80.
6. Lee R.G. Nonalcoholic steatohepatitis a study of 49 patients . Hum Path. 20:1989;594-598.
7. Bacon B.R., Farahvash M.J., Janney C.G., Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis an expanded clinical entity . Gastroenterology. 107:1994;1103-1109.
8. Itoh S., Yougel T., Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 82:1987;650-654.
9. Diehl A.M., Goodman Z., Ishak K.G. Alcoholic disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 95:1988;1056-1062.
10. Sheth S.G., Gordon F.D., Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 126:1997;137-145.
11. Falchuk K.R., Fiske S.C., Haggitt R.C., et al. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology. 78:1980;535-541.
12. Stone B.G., Van Thiel D.H. Diabetes mellitus and the liver. Semin Liv Dis. 5:1985;8-28.
13. Foster K.J., Griffith A.H., Dewbury K., et al. Liver disease in patients with diabetes mellitus. Postgrad Med J. 56:1980;767-772.
14. Silverman J.F., Pories W.J., Caro J.F. Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu. 24:1989;275-302.
15. James O.F.W., Day P.D. Nonalcoholic steatohepatitis (NASH) a disease of emerging identity and importance . J Hepatol. 29:1998;495-501.
16. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment insulin resistance and β-cell function from plasma fasting glucose and insulin concentrations in man . Diabetologia. 28:1985;412-419.
17. Phillips D.I.W., Clark P.M., Hales C.N., Osmond C. Understanding oral glucose tolerance comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurement of insulin resistance and insulin secretion . Diabet Med. 11:1994;286-292.
18. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes. 28:1979;1039-1057.
19. Duncan D.B. Multiple range test for correlated and heteroscedastic means. Biometrics. 13:1957;164-204.
20. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ. 292:1986;13-15.
21. Khoo B.C., McQueen M.P., Sandle W.J. Use of texture analysis to discriminate between normal livers and livers with steatosis. J Biomed Engl. 13:1991;489-494.
22. Ricci C., Longo R., Gioulis E., et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 27:1997;108-113.
23. Projetto J., Nankervis A., Aitken P., et al. Insulin resistance in cirrhosis evidence for a post-receptor defect . Clin Endocrinol. 21:1984;677-688.
24. Johnston D.G., Alberti K.G.M.M., Faber O.K., et al. Hyperinsulinism of hepatic cirrhosis diminished degradation or hypersecretion? Lancet. 1:1977;10-13.
25. Marchesini G., Pacini G., Bianchi G.P., et al. Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis. a minimal model assessment. Gastroenterology. 99:1990;1715-1722.
26. Eriksson J., Franssila-Kallunki A, Ekstrand A., et al. Early metabolic defects in persons at increased risk for non-insulin-mediated diabetes mellitus. NEJM. 321:1989;337-343.
27. Lee J.H., Rhee P.L., Lee J.K., et al. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med. 13:1998;12-14.
28. Reaven G.M. Role of insulin resistance in human diabetes. Diabetes. 37:1988;1595-1607.
29. DeFronzo R.A., Ferrannini E. Insulin resistance a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease . Diabetes Care. 14:1991;173-194.
30. Björntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 4:1988;622-627.
31. Marceau P., Biron S., Hould F.S., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 84:1999;1513-1517.
32. Day C.P., James O.F.W. Steatohepatitis a tale of two "hits." Gastroenterology. 114:1998;842-845.
33. George D.K., Goldwurm S., McDonald G.A., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 114:1998;311-318.
34. Morimoto M., Hagbjork A.L., Nanji A.A., et al. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol. 10:1993;459-464.
35. Drenick E.J., Simmons F., Murphy J.F. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. NEJM. 282:1970;829-834.